Table 1.
Multiple regression analyses predicting (a) NoGo N2 amplitude with inhibitory control, attentional control and control variables and (b) the N2 effect (Go–NoGo) with NoGo trials per cent correct and control variables.
| (a) NoGo N2 amplitude | B | β | s.e. | p-value |
|---|---|---|---|---|
| CBQ inhibitory control | 2.91 | 0.25 | 1.09 | <0.01 |
| control variables | ||||
| # NoGo trials included | −0.16 | −0.06 | 0.23 | 0.48 |
| Age (months) | −3.07 | −0.11 | 2.70 | 0.26 |
| Sexa | −1.42 | −0.07 | 1.82 | 0.44 |
| F4,118 = 2.24, p = 0.06, R2 = 0.07 | ||||
| CBQ attentional control | 1.97 | 0.21 | 0.91 | <0.05 |
| control variables | ||||
| # NoGo trials included | −0.11 | −0.05 | 0.23 | 0.62 |
| Age (months) | −3.36 | −0.04 | 2.74 | 0.22 |
| Sexa | −0.79 | −0.11 | 1.79 | 0.66 |
| F4,118 = 1.62, p = 0.17, R2 = 0.05 | ||||
| (b) N2 effect | B | β | s.e. | p-value |
|---|---|---|---|---|
| NoGo per cent correct | 0.25 | 0.30 | 0.09 | <0.01 |
| control variables | ||||
| # NoGo trials included | −0.40 | −0.12 | 0.36 | 0.27 |
| Age (months) | −6.27 | −0.15 | 3.56 | 0.08 |
| Sexa | −2.15 | −0.08 | 2.23 | 0.34 |
| F4,125 = 3.30, p < 0.05, R2 = 0.10 | ||||
a0 = male, 1 = female.